Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to define th Maximum Tolerated Dose (MTD) and the recommended
dose (RD) of ZD6474 in combination with a fixed standard dose of gemcitabine and capecitabine